Skip to content

Biodesix, Inc. BDSX Change in AP

Change in AP at other companies

NeoGenomics logo
NeoGenomicsNEO
$718K-37.2%
Veracyte logo
VeracyteVCYT
$2.59M-63.7%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
-$7.51M+22.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$809K-140%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-$50.55M-314%
GeneDx Holdings logo
GeneDx HoldingsWGS
-$13.17M-222%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s change in AP?
Biodesix, Inc. (BDSX) reported change in AP of -$2.34M in Q1 2026.
How has Biodesix, Inc.'s change in AP changed year-over-year?
Biodesix, Inc.'s change in AP decreased by 20.9% year-over-year, from -$1.94M to -$2.34M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.